Financials
- Market Capitalization 1.28 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.74
市销率
941.13
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2218 | ANAB AnaptysBio, Inc. - Common Stock | 45.59 USD | -0.98% | -4.80% | -16.46% | +29.52% | 1.33 B USD | ||
| 2227 | NKTR Nektar Therapeutics - Common Stock | 37.91 USD | -4.84% | -5.01% | -45.84% | -48.26% | 1.29 B USD | ||
| 2264 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 13.95 USD | -15.71% | -19.69% | -23.60% | -7.00% | 1.25 B USD | ||
| 2267 | DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 13.74 USD | -3.65% | -5.11% | -2.62% | +251.41% | 1.21 B USD |